Juana Ciudad Pizarro-rekin lankidetzan egindako argitalpenak (23)

2003

  1. Minimal residual disease in adolescent (older than 14 years) and adult acute lymphoblastic leukemias: Early immunophenotypic evaluation has high clinical value

    Blood, Vol. 101, Núm. 12, pp. 4695-4700

2000

  1. BIOMED-1 Concerted Action report: Flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL)

    Leukemia, Vol. 14, Núm. 5, pp. 816-825

1999

  1. An abnormal CD34+ myeloid/CD34+ lymphoid ratio at the end of chemotherapy predicts relapse in patients with acute myeloid leukemia

    Communications in Clinical Cytometry, Vol. 38, Núm. 2, pp. 70-75

  2. Detection of abnormalities in B-cell differentiation pattern is a useful tool to predict relapse in precursor-B-ALL

    British Journal of Haematology, Vol. 104, Núm. 4, pp. 695-705

  3. Immunophenotypical detection of minimal residual disease in acute leukemia

    Critical Reviews in Oncology/Hematology, Vol. 32, Núm. 3, pp. 175-185

1998

  1. Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: Implications for minimal residual disease detection

    Haematologica, Vol. 83, Núm. 12, pp. 1069-1075

  2. Immunophenotypic characterization of human bone marrow mast cells. A flow cytometric study of normal and pathological bone marrow samples

    Analytical Cellular Pathology, Vol. 16, Núm. 3, pp. 151-159

  3. Increased interleukin-12 serum levels in chronic alcoholism

    Journal of Hepatology, Vol. 28, Núm. 5, pp. 771-777

  4. Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia

    Journal of Clinical Oncology, Vol. 16, Núm. 12, pp. 3774-3781

1996

  1. Flow cytometric analysis of mast cells from normal and pathological human bone marrow samples: Identification and enumeration

    American Journal of Pathology, Vol. 149, Núm. 5, pp. 1493-1499

  2. Long lasting immunological effects of ethanol after withdrawal

    Communications in Clinical Cytometry, Vol. 26, Núm. 4, pp. 275-280

  3. Multiparametric cell-cycle analysis of peripheral blood-activated lymphocyte subsets using staining based on the TdT method for incorporated BrdUrd

    Cytometry, Vol. 25, Núm. 4, pp. 317-323

1995

  1. Clinical, biological, and immunophenotypical characteristics of B‐cell chronic lymphocytic leukemia with trisomy 12 by fluorescence in situ hybridization

    Cytometry, Vol. 22, Núm. 3, pp. 217-222

  2. Flow cytometry in the diagnosis of cancer

    Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 55, Núm. S221, pp. 145-152

  3. Phenotypic analysis of CD34 subpopulations in normal human bone marrow and its application for the detection of minimal residual disease

    Leukemia, Vol. 9, Núm. 11, pp. 1896-1901

  4. Prognostic value of S-phase cells in AML patients

    British Journal of Haematology, Vol. 89, Núm. 2, pp. 342-348

1994

  1. Acute lymphoblastic leukemia (ALL): Detection of minimal residual disease (MRD) at flow cytometry

    Leukemia and Lymphoma, Vol. 13, Núm. s1, pp. 87-90

  2. Phenotypic characterization of normal myeloid differentiation

    Sangre, Vol. 39, Núm. 4, pp. 277-282

1993

  1. Immunophenotypic characterisation of acute leukaemia after polycythemia vera Servico de

    Journal of Clinical Pathology, Vol. 46, Núm. 7, pp. 668-671

  2. La citometría de flujo en el diagnóstico clínico

    Análisis y metodologías en diagnóstico y terapia génica: I reunión científica en biología celular y molecular : [La Coruña, noviembre 1992]